| low-frequency variant |
variant |
5 |
1 |
MAF 0.5%–5% variant, low minor allele frequency variant, low-frequency variants |
| Low income |
phenotype |
9 |
5 |
earn less than $20,000, household income below $20,000, lowest income |
| low IQ |
phenotype |
5 |
2 |
IQ below 70, low IQ, low intelligence quotient |
| low MAF SNPs |
variant |
2 |
2 |
low minor allele frequency SNPs |
| low mood |
phenotype |
3 |
1 |
|
| low-risk group |
cohort |
2 |
1 |
|
| low-risk individuals |
cohort |
2 |
— |
|
| low self-esteem |
phenotype |
2 |
2 |
self-esteem |
| LOX |
gene |
2 |
1 |
lipoxygenase |
| LPS |
drug |
12 |
6 |
L4391, Lipopolysaccharide, endotoxin, lipopolysaccharide, plasma LPS |
| LRFN5 |
gene |
3 |
3 |
Leucine rich repeat fibronectin type III domain containing 5 |
| LRP1 |
gene |
2 |
2 |
LDLR-related protein 1, LRP-1 |
| LRP5 |
gene |
2 |
2 |
Low-density lipoprotein receptor-related protein 5, Lrp5, low-density lipoprotein receptor-related protein 5 |
| LRR |
drug |
2 |
— |
Log R Ratio, Log R ratio |
| LTB4 |
drug |
2 |
1 |
leukotriene B4 |
| LTP |
phenotype |
12 |
11 |
LTP, LTP facilitation, hippocampal long-term potentiation, long-term potentiation, long-term potentiation induction |
| luciferase |
drug |
9 |
6 |
LUC, luciferase enzyme, luciferase reporter gene |
| lung adenocarcinoma |
phenotype |
5 |
1 |
LUAD |
| lung cancer |
phenotype |
45 |
31 |
LC, human lung cancer, lung cancer, lung cancer risk, lung carcinoma |
| lung cancer patients |
cohort |
6 |
2 |
cancer patients |
